Oral glucocorticoid-induced fall in cortical bone volume and density in postmenopausal asthmatic patients

H. Tsugeno, B. Goto, T. Fujita, M. Okamoto, T. Mifune, Fumihiro Mitsunobu, Kozo Ashida, Y. Hosaki, T. Tsuji, Y. Tanizaki

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Despite a deepening understanding of the influence of glucocorticoids (GC) on trabecular bone, little is known about GC-induced cortical bone loss. To elucidate the mechanism of GC-induced loss of cortical bone strength with particular reference to cortical bone loss, changes in cortical density, relative cortical volume, and the Strength Strain Index (SSI) based on biomechanical analyses of the geographic distribution of cortical bone material were measured. These parameters were compared, using peripheral quantitative computed tomography (pQCT), among the following age-matched groups: 68 postmenopausal asthmatic patients receiving high-dose oral GC in addition to inhaled GC (oral GC group), 68 postmenopausal asthmatic patients receiving only inhaled GC (inhaled GC group) and 69 postmenopausal controls without asthma or GC therapy (control group). Cortical bone mineral density (BMD) was measured, relative cortical volume was obtained by dividing the cortical area by the total bone area using pQCT (Stratec XCT960), and the Strength Strain Index (SSI) was calculated in the radius based on the density distribution around the axis. Spinal fracture was assessed on lateral radiographs. The number of vertebral fractures per patient correlated highly with cortical BMD, relative cortical volume and SSI values at the radius. The number of vertebral fractures per patient and the number of patients with fracture were similar between the control and inhaled GC group, both being significantly lower than those in the oral GC group. Total BMD, trabecular BMD, cortical BMD, relative cortical volume and SSI were similar between the first two, being significantly higher than in the last group. The slopes of cortical volume-density relationship, however, were identical among the three groups, indicating the persistence of cortical bone remodeling and a similar degree of calcification regardless of GC administration.

Original languageEnglish
Pages (from-to)266-270
Number of pages5
JournalOsteoporosis International
Volume12
Issue number4
DOIs
Publication statusPublished - 2001

Fingerprint

Bone Density
Glucocorticoids
Cortical Bone
Tomography
Spinal Fractures
Specific Gravity
Bone Remodeling
Research Design
Asthma
Age Groups
Bone and Bones
Control Groups

Keywords

  • Asthma
  • Cortical bone
  • Glucocorticoids
  • Peripheral quantitative computed tomography

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Oral glucocorticoid-induced fall in cortical bone volume and density in postmenopausal asthmatic patients. / Tsugeno, H.; Goto, B.; Fujita, T.; Okamoto, M.; Mifune, T.; Mitsunobu, Fumihiro; Ashida, Kozo; Hosaki, Y.; Tsuji, T.; Tanizaki, Y.

In: Osteoporosis International, Vol. 12, No. 4, 2001, p. 266-270.

Research output: Contribution to journalArticle

Tsugeno, H, Goto, B, Fujita, T, Okamoto, M, Mifune, T, Mitsunobu, F, Ashida, K, Hosaki, Y, Tsuji, T & Tanizaki, Y 2001, 'Oral glucocorticoid-induced fall in cortical bone volume and density in postmenopausal asthmatic patients', Osteoporosis International, vol. 12, no. 4, pp. 266-270. https://doi.org/10.1007/s001980170115
Tsugeno, H. ; Goto, B. ; Fujita, T. ; Okamoto, M. ; Mifune, T. ; Mitsunobu, Fumihiro ; Ashida, Kozo ; Hosaki, Y. ; Tsuji, T. ; Tanizaki, Y. / Oral glucocorticoid-induced fall in cortical bone volume and density in postmenopausal asthmatic patients. In: Osteoporosis International. 2001 ; Vol. 12, No. 4. pp. 266-270.
@article{923ff70250e4472ea64e9674004fbfd9,
title = "Oral glucocorticoid-induced fall in cortical bone volume and density in postmenopausal asthmatic patients",
abstract = "Despite a deepening understanding of the influence of glucocorticoids (GC) on trabecular bone, little is known about GC-induced cortical bone loss. To elucidate the mechanism of GC-induced loss of cortical bone strength with particular reference to cortical bone loss, changes in cortical density, relative cortical volume, and the Strength Strain Index (SSI) based on biomechanical analyses of the geographic distribution of cortical bone material were measured. These parameters were compared, using peripheral quantitative computed tomography (pQCT), among the following age-matched groups: 68 postmenopausal asthmatic patients receiving high-dose oral GC in addition to inhaled GC (oral GC group), 68 postmenopausal asthmatic patients receiving only inhaled GC (inhaled GC group) and 69 postmenopausal controls without asthma or GC therapy (control group). Cortical bone mineral density (BMD) was measured, relative cortical volume was obtained by dividing the cortical area by the total bone area using pQCT (Stratec XCT960), and the Strength Strain Index (SSI) was calculated in the radius based on the density distribution around the axis. Spinal fracture was assessed on lateral radiographs. The number of vertebral fractures per patient correlated highly with cortical BMD, relative cortical volume and SSI values at the radius. The number of vertebral fractures per patient and the number of patients with fracture were similar between the control and inhaled GC group, both being significantly lower than those in the oral GC group. Total BMD, trabecular BMD, cortical BMD, relative cortical volume and SSI were similar between the first two, being significantly higher than in the last group. The slopes of cortical volume-density relationship, however, were identical among the three groups, indicating the persistence of cortical bone remodeling and a similar degree of calcification regardless of GC administration.",
keywords = "Asthma, Cortical bone, Glucocorticoids, Peripheral quantitative computed tomography",
author = "H. Tsugeno and B. Goto and T. Fujita and M. Okamoto and T. Mifune and Fumihiro Mitsunobu and Kozo Ashida and Y. Hosaki and T. Tsuji and Y. Tanizaki",
year = "2001",
doi = "10.1007/s001980170115",
language = "English",
volume = "12",
pages = "266--270",
journal = "Osteoporosis International",
issn = "0937-941X",
publisher = "Springer London",
number = "4",

}

TY - JOUR

T1 - Oral glucocorticoid-induced fall in cortical bone volume and density in postmenopausal asthmatic patients

AU - Tsugeno, H.

AU - Goto, B.

AU - Fujita, T.

AU - Okamoto, M.

AU - Mifune, T.

AU - Mitsunobu, Fumihiro

AU - Ashida, Kozo

AU - Hosaki, Y.

AU - Tsuji, T.

AU - Tanizaki, Y.

PY - 2001

Y1 - 2001

N2 - Despite a deepening understanding of the influence of glucocorticoids (GC) on trabecular bone, little is known about GC-induced cortical bone loss. To elucidate the mechanism of GC-induced loss of cortical bone strength with particular reference to cortical bone loss, changes in cortical density, relative cortical volume, and the Strength Strain Index (SSI) based on biomechanical analyses of the geographic distribution of cortical bone material were measured. These parameters were compared, using peripheral quantitative computed tomography (pQCT), among the following age-matched groups: 68 postmenopausal asthmatic patients receiving high-dose oral GC in addition to inhaled GC (oral GC group), 68 postmenopausal asthmatic patients receiving only inhaled GC (inhaled GC group) and 69 postmenopausal controls without asthma or GC therapy (control group). Cortical bone mineral density (BMD) was measured, relative cortical volume was obtained by dividing the cortical area by the total bone area using pQCT (Stratec XCT960), and the Strength Strain Index (SSI) was calculated in the radius based on the density distribution around the axis. Spinal fracture was assessed on lateral radiographs. The number of vertebral fractures per patient correlated highly with cortical BMD, relative cortical volume and SSI values at the radius. The number of vertebral fractures per patient and the number of patients with fracture were similar between the control and inhaled GC group, both being significantly lower than those in the oral GC group. Total BMD, trabecular BMD, cortical BMD, relative cortical volume and SSI were similar between the first two, being significantly higher than in the last group. The slopes of cortical volume-density relationship, however, were identical among the three groups, indicating the persistence of cortical bone remodeling and a similar degree of calcification regardless of GC administration.

AB - Despite a deepening understanding of the influence of glucocorticoids (GC) on trabecular bone, little is known about GC-induced cortical bone loss. To elucidate the mechanism of GC-induced loss of cortical bone strength with particular reference to cortical bone loss, changes in cortical density, relative cortical volume, and the Strength Strain Index (SSI) based on biomechanical analyses of the geographic distribution of cortical bone material were measured. These parameters were compared, using peripheral quantitative computed tomography (pQCT), among the following age-matched groups: 68 postmenopausal asthmatic patients receiving high-dose oral GC in addition to inhaled GC (oral GC group), 68 postmenopausal asthmatic patients receiving only inhaled GC (inhaled GC group) and 69 postmenopausal controls without asthma or GC therapy (control group). Cortical bone mineral density (BMD) was measured, relative cortical volume was obtained by dividing the cortical area by the total bone area using pQCT (Stratec XCT960), and the Strength Strain Index (SSI) was calculated in the radius based on the density distribution around the axis. Spinal fracture was assessed on lateral radiographs. The number of vertebral fractures per patient correlated highly with cortical BMD, relative cortical volume and SSI values at the radius. The number of vertebral fractures per patient and the number of patients with fracture were similar between the control and inhaled GC group, both being significantly lower than those in the oral GC group. Total BMD, trabecular BMD, cortical BMD, relative cortical volume and SSI were similar between the first two, being significantly higher than in the last group. The slopes of cortical volume-density relationship, however, were identical among the three groups, indicating the persistence of cortical bone remodeling and a similar degree of calcification regardless of GC administration.

KW - Asthma

KW - Cortical bone

KW - Glucocorticoids

KW - Peripheral quantitative computed tomography

UR - http://www.scopus.com/inward/record.url?scp=0035552825&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035552825&partnerID=8YFLogxK

U2 - 10.1007/s001980170115

DO - 10.1007/s001980170115

M3 - Article

C2 - 11420775

AN - SCOPUS:0035552825

VL - 12

SP - 266

EP - 270

JO - Osteoporosis International

JF - Osteoporosis International

SN - 0937-941X

IS - 4

ER -